These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 3136699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Study on the correlation between tissue uptake of anticancer agents and prognosis -- with special reference to Tegafur].
    Arima S, Futami K, Kinashi M, Shigeta M, Jyozaki H, Shimura H.
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1788-95. PubMed ID: 6411003
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients.
    Kochi M, Fujii M, Kanamori N, Kaiga T, Aizaki K, Takahashi T, Takayama T.
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):693-701. PubMed ID: 17690883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K, Mochizuki Y, Machida T, Yokoyama S, Sodeyama H, Sode Y, Wakabayashi M, Kawamura N, Miyazaki T.
    Hepatogastroenterology; 1999 Oct; 46(26):1238-43. PubMed ID: 10370699
    [Abstract] [Full Text] [Related]

  • 9. Postoperative chemotherapy in elderly patients with advanced gastric cancer.
    Hanazaki K, Mochizuki Y, Igarashi J, Yokoyama S, Sodeyama H, Sode Y, Wakabayashi M, Kawamura N, Miyazaki T, Amano J.
    Hepatogastroenterology; 2000 Oct; 47(36):1761-4. PubMed ID: 11149051
    [Abstract] [Full Text] [Related]

  • 10. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y, Kamoshida S, Furuta S, Sunagawa R, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [Abstract] [Full Text] [Related]

  • 11. [Adjuvant chemotherapy after surgery in advanced gastric cancer].
    Hirose S, Mano K, Kataoka K, Kitamura M, Tsutsui N, Ohara T, Kimura H, Hamaya K.
    Gan No Rinsho; 1984 Nov; 30(14):1767-72. PubMed ID: 6439912
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S, Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group.
    J Clin Oncol; 2003 Jun 15; 21(12):2282-7. PubMed ID: 12805327
    [Abstract] [Full Text] [Related]

  • 14. [Tissue concentration of 5-FU following pre-operative administration of FT-207].
    Sarashina H, Ozaki A, Okamura T, Fukao K, Takase Y, Takeshima T, Todoroki T, Ishikawa A, Orii K, Nagoshi K, Iwasaki Y.
    Gan To Kagaku Ryoho; 1982 Jul 15; 9(7):1277-84. PubMed ID: 6820912
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetics of 5-FU after S-1 oral administration for adjuvant chemotherapy in gastric cancer patients].
    Matsumoto H, Hirai T, Hirabayashi Y, Murakami H, Higashida M, Kawabe Y, Fuchimoto M, Fujikura H, Hato S, Urakami A, Yamashita K, Tsunoda T.
    Gan To Kagaku Ryoho; 2007 Jun 15; 34(6):869-73. PubMed ID: 17565248
    [Abstract] [Full Text] [Related]

  • 16. [Adjuvant chemotherapy for gastric cancer--relation between long-term administration of FT-207 and prognosis].
    Tanaka T, Inaba S, Naito K, Iguchi K, Yamagishi H, Kobayashi M.
    Gan To Kagaku Ryoho; 1984 Jan 15; 11(1):130-7. PubMed ID: 6421240
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, Beretta GD, Catalano V, Bertetto O, Barni S, Frontini L, Aitini E, Rota S, Torri V, Floriani I, Italian Group for the Study of Digestive Tract Cancer, Pozzo C, Rimassa L, Mosconi S, Giordani P, Ardizzoia A, Foa P, Rabbi C, Chiara S, Gasparini G, Nardi M, Mansutti M, Arnoldi E, Piazza E, Cortesi E, Pucci F, Silva RR, Sobrero A, Ravaioli A.
    J Natl Cancer Inst; 2007 Apr 18; 99(8):601-7. PubMed ID: 17440161
    [Abstract] [Full Text] [Related]

  • 18. Influence of gastrectomy on the distribution of intravenously administered 5-fluorouracil to regional lymph nodes in an animal model.
    Seto Y, Takenoue T, Nariko H, Kaminishi M.
    Cancer; 2000 Jun 01; 88(11):2443-6. PubMed ID: 10861418
    [Abstract] [Full Text] [Related]

  • 19. [Effect of adjuvant chemotherapy for patients with early gastric cancer].
    Sasaki A, Furusawa M, Tomoda H, Seo Y, Ohno S, Matsukuma A, Morita M, Kakeji Y.
    Gan To Kagaku Ryoho; 1994 Jan 01; 21(1):37-45. PubMed ID: 8291914
    [Abstract] [Full Text] [Related]

  • 20. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M, Sakabe T, Wakabayashi K, Kochi M, Mochizuki F, Kasakura Y, Yamagata M, Noro M, Osawa T, Iwai S.
    Gan To Kagaku Ryoho; 1994 Jul 01; 21(8):1199-208. PubMed ID: 8031162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.